Researchers at McMaster University are leading preclinical studies into a novel drug candidate developed by Espervita ...

Prof. Liu Cong from the Shanghai Institute of Organic Chemistry of the Chinese Academy of Sciences, along with collaborators, ...

The nearly 30-year tale of secalosides A and B began in 1997, when natural product chemists identified them as components of ...

Kanazawa University, have captured real-time images showing how a key brain enzyme organizes itself to help memory formation.

An international research team reveals new molecular mechanisms associated with pathogenic mutations in the protein ...

Enfortumab vedotin and pembrolizumab significantly improved survival outcomes in muscle-invasive bladder cancer, surpassing standard chemotherapy for cisplatin-eligible patients. The trial ...

Despite recent progress in understanding the disease, inflammatory breast cancer (IBC) remains a challenge to diagnose and treat, and the prognosis remains worse than for breast cancer in general. IBC ...

Pembrolizumab and enfortumab vedotin combination is approved for muscle-invasive bladder cancer in cisplatin-ineligible patients, offering a new treatment option with improved outcomes. The ...

Genesis’ proprietary foundation model – Pearl – outperforms frontier models, including AlphaFold 3, on key benchmarks that predict utility in real-world drug discovery Pearl’s performance improved ...

Perioperative enfortumab vedotin and pembrolizumab improved the pathologic complete response rate, event-free survival, and overall survival. The addition of perioperative enfortumab vedotin (EV) and ...

Researchers at Google Quantum AI have used their Willow quantum computer to help interpret data from Nuclear Magnetic Resonance (NMR) spectroscopy, a mainstay of chemistry and biology research. The ...